Dew I have never understood about the newer anticoagulants monitoring. Is there just no test to monitor them or do they really need no monitoring? The latter point seems counterintuitive to me.
Is ARYX still on schedule for its trial? What do you think of this drug?
The stock seems awfully cheap with the anti-coagulant and the atrial fibrillation drug. Goddard, the CEO, is promising two major partnerships by the end of the year.
Anyone here follow ARYX?
PGS, what do you think of the atrial fibrillation drug?
News 
Market Data 
Discover 
